Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies PharmaCyte Biotech, Inc. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dov Elefant - $50K in FEMY purchases and sales in the last 12 months
- Kathy Lee-Sepsick - $50K in FEMY purchases and sales in the last 12 months
- John Charles Canning - $14K in FEMY purchases and sales in the last 12 months
- Jeremy Alexander Sipos - $10K in FEMY purchases and sales in the last 12 months
- Chelsea Sierra Voss - $6K in QCLS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is PharmaCyte Biotech, Inc.?
PharmaCyte Biotech, Inc. is a corporate entity, tracked as 10% Owner of FEMASYS INC (FEMY). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did PharmaCyte Biotech, Inc. last file a Form 4?
The most recent primary Form 4 on record is dated 18 March 2026, one of 2 filings going back to 2025.
Has PharmaCyte Biotech, Inc. been buying or selling stock?
Recorded transactions: 2 open-market purchases and 0 open-market sales across all tracked filings.
